EDEN PRAIRIE, Minn.--(EON: Enhanced Online News)--SurModics, Inc. (Nasdaq: SRDX), a leading provider of surface modification and in vitro diagnostic technologies to the healthcare industry, announced today that it will host a live webcast of its fourth quarter and fiscal year 2013 conference call on Tuesday, November 5, at 4:00 p.m. CT (5:00 p.m. ET). The Company will issue an earnings news release after the market closes that afternoon.
Gary Maharaj, chief executive officer, and Andy LaFrence, vice president of finance and chief financial officer, will recap the fourth quarter and fiscal year 2013 financial results and accomplishments as well as provide fiscal 2014 guidance. To access the webcast, go to the investor relations portion of the Company’s website at www.surmodics.com the day of the conference call and click on the webcast icon.
An audio replay will be available beginning at 7:00 p.m. CT on Tuesday, November 5, until 7:00 p.m. CT on Tuesday, November 12, and can be accessed by dialing 800-406-7325 and entering conference call ID passcode 4647280. In addition, the conference call audio and transcript will be archived on the Company’s website following the call.
About SurModics, Inc.
SurModics’ mission is to exceed our customers’ expectations and enhance the well-being of patients by providing the world’s foremost, innovative surface modification technologies and in vitro diagnostic chemical components. The Company partners with the world’s leading and emerging medical device, diagnostic and life science companies to develop and commercialize innovative products designed to improve patient diagnosis and treatment. Core offerings include surface modification coating technologies that impart lubricity, prohealing, and biocompatibility capabilities; and components for in vitro diagnostic test kits and microarrays. SurModics is headquartered in Eden Prairie, Minnesota. For more information about the Company, visit http://www.surmodics.com. The content of SurModics’ website is not part of this press release or part of any filings that the Company makes with the SEC.